Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | TNF-a | 100 | ng/mL | 2 | MMP-2 | 232.5 | 24 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MMP-2 | 64.5 | 44 | |
N2645 | TNF-a | 100 | ng/mL | 2 | MMP-2 | 63.0 | 50 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | MMP-2 | 349.5 | 22 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | MMP-2 | 328.0 | 28 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-2 | 192.0 | 21 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-2 | 254.0 | 36 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-2 | 55.5 | 54 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-2 | 65.0 | 49 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-2 | 303.5 | 40 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-2 | 308.5 | 50 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-2 | 286.0 | 30 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 2 | MMP-2 | 260.0 | 41 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-2 | 60.0 | 41 | |
N2645 | IL-1 alpha | 100 | ng/mL | 2 | MMP-2 | 63.0 | 39 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 2 | MMP-2 | 432.0 | 31 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 2 | MMP-2 | 322.5 | 26 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-2 | 217.0 | 33 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-2 | 341.0 | 31 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-2 | 65.5 | 30 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-2 | 57.0 | 45 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-2 | 300.0 | 31 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-2 | 353.0 | 46 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | MMP-2 | 178.0 | 40 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | MMP-2 | 309.0 | 25 |